Key result
Cine-CMR lateral MAPSE linked to ~37% higher MACE risk, improving traditional risk reclassification.
Why the study?
The prognostic value of lateral MAPSE for predicting MACE in patients with suspected CAD needed evaluation.
Does lateral MAPSE measurement improve prediction of MACE in patients with suspected coronary artery disease?
Cohort (n=233)
Does lateral MAPSE measurement improve prediction of MACE in patients with suspected coronary artery disease?
Effect estimate: HR 1.373
p-value: p=0.020
Lateral MAPSE derived from cine-CMR is an independent predictor of MACE and significantly improves risk stratification beyond traditional clinical and CMR risk factors in patients with suspected CAD.
May aid MACE risk stratification in suspected CAD; leaves open whether it should guide decisions pending validation.
To evaluate the prognostic value of lateral mitral annular plane systolic excursion (MAPSE) in the prediction of major adverse cardiology events (MACE) in patients with suspected coronary artery disease (CAD). 233 consecutive patients were enrolled with suspected CAD from October 2012 to September 2013 and performed contrast-enhanced cardiac magnetic resonance (CMR) and two-dimensional echocardiogram studies no later than 72 h after admission. CMR imaging protocol included 4-chamber cine(cine-CMR), cardiovascular magnetic resonance angiography (CMRA) and late gadolinium enhancement (LGE). The primary endpoint is the time of first occurrence of a MACE The independent association between lateral MAPSE and MACE was evaluated by Kaplan-Meier analysis and multivariable Cox regression analysis. C statistic and net reclassification improvement (NRI) were used to evaluate the prognostic value of lateral MAPSE in MACE. Forty-five MACE occurred during an average follow-up of 9.2 years. Patients with lateral MAPSE<9.885 mm experienced a significantly higher incidence of MACE than patients with lateral MAPSE ≥ 9.885 mm ( P <0.001). After adjustment for established univariate predictors (age, diabetes, hypertension, hypercholesterolemia, transmural myocardial infarction), lateral MAPSE remained a significant independent predictor of MACE (HR = 1.373; P = 0.020). The incorporation of lateral MAPSE into the risk model resulted in significant improvement in C statistic (increasing from 0.668 to 0.844; P = 0.005). NRI improvement was 0.33 ( P <0.001). lateral MAPSE derived from cine-CMR is an independent predictor of MACE, and improve risk reclassification beyond traditional clinical and CMR risk factors in patients with suspected coronary disease.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2024) conducted a cohort in Suspected coronary artery disease (CAD) (n=233). Lateral MAPSE < 9.885 mm vs. Lateral MAPSE ≥ 9.885 mm was evaluated on Time of first occurrence of a major adverse cardiology event (MACE) (HR 1.373, p=0.020). Lateral MAPSE derived from cine-CMR was an independent predictor of MACE (HR 1.373; P=0.020) and significantly improved risk reclassification beyond traditional clinical and CMR risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: